☆ 4.6 Article

CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium

ALLERGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury

Haiying Zhang et al.

Summary: The drug CU06-1004 has shown potential in improving cardiac function by inhibiting CMEC hyperpermeability and reducing inflammation and infiltration in infarcted hearts. It enhances vascular integrity, reduces tissue damage, and provides a promising therapeutic option for preventing lethal myocardial I/R injury.

EXPERIMENTAL AND MOLECULAR MEDICINE (2022)

Add to Collection

Review Allergy

Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade

Paula Busse et al.

Summary: This article provides an overview of hereditary angioedema (HAE), a rare genetic disease characterized by nonpruritic angioedema. The study discusses the classification of HAE and the underlying genetic mutations that cause the condition. It also explores the mechanism of HAE and the development of plasma kallikrein inhibitors as a treatment option. The article highlights the importance of understanding and managing HAE to improve patient outcomes.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Add to Collection

Article Medicine, Research & Experimental

CU06-1004 modulates the adenosine monophosphate (AMP)-associated protein kinase (AMPK) signaling pathway and inhibits lipogenesis in 3T3-L1 adipocytes and high-fat diet-induced obese mice

Cho-Rong Bae et al.

Summary: The endothelial dysfunction blocker CU06-1004 was found to reduce lipid accumulation and improve insulin resistance and hepatic steatosis. This may make it a potential therapeutic agent for the prevention of obesity and obesity-related disorders.

LIFE SCIENCES (2022)

Add to Collection

Article Allergy

Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2

Laure M. Fijen et al.

Summary: Hereditary angioedema (HAE) is a rare disease characterized by episodic attacks of swelling, caused by uncontrolled activation of the kinin system. Recent advances in targeted therapies have provided more effective and convenient treatment options for HAE patients, with the potential to reduce the burden on patients.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies

Lena Claesson-Welsh et al.

Summary: The leakage of blood vessels into tissues is regulated by mechanisms controlling endothelial barrier function. Research on endothelial permeability has provided valuable insights, but ongoing questions and controversies complicate interpretation in the context of vascular physiology and pathophysiology.

TRENDS IN MOLECULAR MEDICINE (2021)

Add to Collection

Article Immunology

CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells

Songyi Park et al.

Summary: Stabilizing tumor blood vessels and modifying the tumor microenvironment with the endothelial dysfunctional blocker CU06-1004 can synergize with anti-PD-1 immunotherapy, leading to decreased tumor growth, increased T-cell infiltration and activity, reduced hypoxia, and vessel density. These effects are significantly associated with enhanced expression of IFN gamma and PD-L1 in tumors.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Allergy

Treatment of Hereditary Angioedema

T. Caballero

Summary: This review explores the current therapy for hereditary angioedema due to C1-esterase inhibitor deficiency (C1-INH-HAE) and provides a brief overview of drugs under development. Pharmacological treatment is based on three pillars: treatment of acute attacks, short-term prophylaxis, and long-term prophylaxis. New drugs targeting the kallikrein-kinin system are being investigated for long-term prophylaxis in C1-INH-HAE patients.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Allergy

Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?

Marta L. Debreczeni et al.

Summary: Bradykinin plays a key role in angioedema, but other factors can also affect vascular endothelial cell integrity and participate in regulating angioedema formation. By unraveling the complex scenario of vascular permeability regulation and edema formation, we may gain better scientific tools to predict and treat not only bradykinin-mediated angioedema but also other types of angioedema.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Hereditary angioedema patients would prefer newer-generation oral prophylaxis

Daniela Geba et al.

Summary: Most patients with HAE prefer a newer generation oral prophylactic medication that would decrease treatment burden and allow them to live fuller lives. The majority of patients surveyed believe it is important to take preventative medication as prescribed, but over half find HAE prophylactic treatment burdensome. Despite liking their current medications, nearly all prophylactic HAE medication users would prefer an oral treatment if available.

JOURNAL OF DRUG ASSESSMENT (2021)

Add to Collection

Article Genetics & Heredity

CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury

Dong Young Kim et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2020)

Add to Collection

Article Pharmacology & Pharmacy

CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction

Ye-Seul Kim et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Hereditary angioedema: an update on causes, manifestations and treatment

Hilary J. Longhurst et al.

BRITISH JOURNAL OF HOSPITAL MEDICINE (2019)

Add to Collection

Editorial Material Medicine, Research & Experimental

The hereditary angioedema syndromes

Alvin H. Schmaier

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection

Article Medicine, General & Internal

Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function

Maddalena Alessandra Wu et al.

FRONTIERS IN MEDICINE (2019)

Add to Collection

Article Multidisciplinary Sciences

Whole-mount Confocal Microscopy for Adult Ear Skin: A Model System to Study Neuro-vascular Branching Morphogenesis and Immune Cell Distribution

Tomoko Yamazaki et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)

Add to Collection

Review Medicine, General & Internal

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease

William Raymond Lumry

FRONTIERS IN MEDICINE (2018)

Add to Collection

Article Immunology

Sac-1004, a vascular leakage blocker, reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation

Haiying Zhang et al.

JOURNAL OF NEUROINFLAMMATION (2017)

Add to Collection

Review Pathology

Disorders of Vascular Permeability

Cindy Park-Windhol et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Combined effect of vascular-leakage-blocker Sac-1004 and antiangiogenic drug sunitinib on tumor angiogenesis

Keunho Lee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Add to Collection

Article Allergy

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II

Erika Kajdacsi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Article Cell Biology

Endothelial permeability and VE-cadherin

Julie Gavard

Cell Adhesion & Migration (2014)

Add to Collection

Article Oncology

Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice

Vijayendra Agrawal et al.

ONCOTARGET (2014)

Add to Collection

Review Obstetrics & Gynecology

Management of hereditary angioedema in pregnant women: a review

Teresa Caballero et al.

INTERNATIONAL JOURNAL OF WOMENS HEALTH (2014)

Add to Collection

Article Allergy

Assessment of hereditary angioedema treatment risks

Shana Kalaria et al.

ALLERGY AND ASTHMA PROCEEDINGS (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Sac-1004, a novel. vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway

Sony Maharjan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Add to Collection

Article Multidisciplinary Sciences

Tyrosine 416 Is Phosphorylated in the Closed, Repressed Conformation of c-Src

Sevgi Irtegun et al.

PLOS ONE (2013)

Add to Collection

Article Multidisciplinary Sciences

An in vivo Assay to Test Blood Vessel Permeability

Maria Radu et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)

Add to Collection

Review Physiology

Studies on the cell biology of interendothelial cell gaps

Cristhiaan D. Ochoa et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo

Fabrizio Orsenigo et al.

NATURE COMMUNICATIONS (2012)

Add to Collection

Review Allergy

New topics in bradykinin research

M. Maurer et al.

ALLERGY (2011)

Add to Collection

Letter Allergy

Hereditary angioedema: Key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation

Laurence Bouillet et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Add to Collection

Article Allergy

Bradykinin and the Pathogenesis of Hereditary Angioedema

Allen P. Kaplan

WORLD ALLERGY ORGANIZATION JOURNAL (2011)

Add to Collection

Article Allergy

Economic costs associated with acute attacks and long-term management of hereditary angioedema

David A. Wilson et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)

Add to Collection

Review Allergy

The bradykinin-forming cascade and its role in hereditary angioedema

Allen P. Kaplan et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)

Add to Collection

Review Cardiac & Cardiovascular Systems

Myosin light chain kinase in microvascular endothelial barrier function

Qiang Shen et al.

CARDIOVASCULAR RESEARCH (2010)

Add to Collection

Article Biochemistry & Molecular Biology

The plasma bradykinin-forming pathways and its interrelationships with complement

Allen P. Kaplan et al.

MOLECULAR IMMUNOLOGY (2010)

Add to Collection

Editorial Material Peripheral Vascular Disease

Concepts in microvascular endothelial barrier regulation in health and disease

Joe G. N. Garcia

MICROVASCULAR RESEARCH (2009)

Add to Collection

Article Allergy

Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients

Konrad Bork et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)

Add to Collection

Article Cardiac & Cardiovascular Systems

Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules

F Baffert et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)

Add to Collection

Review Physiology

Signaling mechanisms regulating endothelial permeability

D Mehta et al.

PHYSIOLOGICAL REVIEWS (2006)

Add to Collection

Article Cardiac & Cardiovascular Systems

Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma

M Cyr et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.